LIFE SCIENCE REIT PLC

Major Shareholding Notification • Jan 28, 2025

National Storage Mechanism | Additional information

RNS Number : 0086V

Life Science REIT PLC

28 January 2025

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BP5X4Q29

Issuer Name

LIFE SCIENCE REIT PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Hazelview Investments Inc.

City of registered office (if applicable)

Toronto

Country of registered office (if applicable)

Canada

4. Details of the shareholder

Name	City of registered office	Country of registered office
Hazelview Securities Inc.	Toronto	Canada
Hazelview Securities (US) LLC	Toronto	Canada

5. Date on which the threshold was crossed or reached

27-Jan-2025

6. Date on which Issuer notified

28-Jan-2025

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	2.950000	0.000000	2.950000	10339530
Position of previous notification (if applicable)	3.160000	0.000000	3.160000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BP5X4Q29	10339530	0	2.950000	0.000000
Sub Total 8.A	10339530		2.950000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Hazelview Investments Inc. (Chain 2)	Hazelview Securities (US) LLC (Subsidiary 2)
Hazelview Investments Inc. (Chain 1)	Hazelview Securities Inc. (Subsidiary 1)

10. In case of proxy voting

Name of the proxy holder

Hazelview Securities Inc. and Hazelview Securities (US) LLC on behalf of its client accounts.

The number and % of voting rights held

2.95

The date until which the voting rights will be held

Until the securities are sold.

11. Additional Information

12. Date of Completion

28-Jan-2025

13. Place Of Completion

Toronto, Ontario, Canada

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLPPURPGUPAGQR